Helene Duret

Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells

Yuting Ma, Sandy Adjemian, Stephen R. Mattarollo et al. · Immunity · 2013 · 667 citations

Tumor Immunology, Cancer Immunosurveillance, Medicine +7

Anti–ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti–PD-1 or anti-CD137 mAb therapy

John Stagg, Sherene Loi, Upulie Divisekera et al. · Proceedings of the National Academy of Sciences · 2011 · 476 citations

CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis

John Stagg, Upulie Divisekera, Helene Duret et al. · Cancer Research · 2011 · 391 citations

T-regulatory Cell, Immunoediting, Immunology +19

Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors

Stephen R. Mattarollo, Sherene Loi, Helene Duret et al. · Cancer Research · 2011 · 322 citations · Full text

Experimental Breast Adenocarcinomas, Innate Immune System, Immunology +25

NLRP3 Suppresses NK Cell–Mediated Responses to Carcinogen-Induced Tumors and Metastases

Melvyn T. Chow, Jaclyn Sceneay, Christophe Paget et al. · Cancer Research · 2012 · 182 citations

Immunology, Immune Regulation, Immunoediting +22